Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?

B. G. Hansson, K. Riesbeck, E. Nordenfelt, O. Weiland

Research output: Contribution to journalArticlepeer-review

Abstract

Foscarnet has been shown to inhibit the proliferation of human T and B lymphocytes in vitro. The production of lymphokines was more strongly affected than the DNA synthesis. Monocyte function was only partly inhibited by the highest foscarnet concentration tried. The influence of foscarnet on the immune system could explain the beneficial effect observed in patients with HBV-related fulminant hepatitis treated with foscarnet.

Original languageEnglish
Pages (from-to)421-427
JournalProgress in Clinical and Biological Research
Volume364
Publication statusPublished - 1991 Jan 1

Subject classification (UKÄ)

  • Microbiology in the medical area

Fingerprint

Dive into the research topics of 'Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?'. Together they form a unique fingerprint.

Cite this